Terms ending in 2041
Every in-force patent on RO5 Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,080,607 | Data Platform for Automated Pharmaceutical Research Using Knowledge Graph In force · High confidence | RO5.ai | In force | High confidence | |
| US 11,176,462 | System and Method for Prediction of Protein-Ligand Interactions and Their Bioactivity In force · High confidence | RO5 Inc. | In force | High confidence | |
| US 11,256,994 | System and Method for Prediction of Protein-Ligand Bioactivity and Pose Propriety In force · High confidence | RO5 Inc. | In force | High confidence | |
| US 11,256,995 | System and Method for Prediction of Protein-Ligand Bioactivity Using Point-Cloud Machine Learning In force · Medium confidence | RO5 Inc. | In force | Medium confidence | |
| US 11,551,109 | System and Method for Patient Health Data Prediction Using Knowledge Graph Analysis In force · Medium confidence | RO5 Inc. | In force | Medium confidence | |
| US 11,568,961 | System and Method for Accelerating Fep Methods Using a 3D-RESTRICTED Variational Autoencoder In force · Medium confidence | RO5 Inc. | In force | Medium confidence | |
| US 11,610,139 | System and Method for the Latent Space Optimization of Generative Machine Learning Models In force · Medium confidence | RO5 Inc. | In force | Medium confidence | |
| US 11,615,324 | System and Method for De Novo Drug Discovery In force · Low confidence | RO5 Inc. | In force | Low confidence | |
| US 11,710,049 | System and Method for the Contextualization of Molecules In force · Medium confidence | RO5 Inc. | In force | Medium confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.